Medical News

RSS

Micromet to present new data from its blinatumomab Phase 1 trial at the ASH meeting

Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced the publication of a poster with new data from its ongoing phase 1 clinical trial of its product candidate blinatumomab in patients with non-Hodgkin's lymphoma (NHL) at the 51ST Annual Meeting of the American Society of Hematology (ASH) in New Orleans, Louisiana.

7 Dec 2009

Atrium Medical commences enrollment in its INFUSE AMI trial

Atrium Medical Corporation announced that the 1st patient was enrolled in the INFUSE AMI trial. INFUSE AMI is a multi-center, multi-national, prospective, randomized, single blind trial examining how patients with heart attacks are treated. The study's aim is to help determine the best way to treat patients with an acute anterior wall myocardial infarction (acute MI) with ST segment elevation, commonly referred to as STEMIs.

7 Dec 2009

New PenLink connectivity package installed at Zwanger-Pesiri Radiology

The Medipattern Corporation, a pioneer in the development of medical software solutions that help improve imaging workflow and productivity, and PenRad Technologies, Inc., a leader in the development of mammography information systems (MIS) are pleased to announce the first installation of the new PenLink connectivity package at Zwanger-Pesiri Radiology, Long Island's largest private medical imaging practice.

7 Dec 2009

First Edition: December 7, 2009

President Obama took to the Hill this weekend to boost Senate Democrats' health reform efforts. Meanwhile, the negotiations on flashpoint issues such as the public option continue.

7 Dec 2009

Native Remedies selects TransMedia Group as its PR firm

With more than 500,000 customers worldwide, the market leader in all-natural herbal and homeopathic remedies for people and their pets, Native Remedies, has engaged TransMedia Group as their PR firm of record. The company's two brands, Native Remedies (www.nativeremedies.com) and PetAlive (www.PetAlive.com), provide complete lines of safe, scientifically-tested, guaranteed products that promote health and wellness - naturally.

7 Dec 2009

New report shows U.S. citizens are ready to make hard choices on fiscal and economic priorities

Hoping to protect their children and grandchildren from a dismal economic future, concerned citizens across the country are prepared to make the difficult choices necessary to put government finances on a more responsible path.

7 Dec 2009

UCB presents data on Vimpat AED at AES meeting

UCB today announced new findings on its antiepileptic drug (AED) Vimpat® that offer additional clinical evidence supporting the use of this AED as adjunctive therapy in adult patients with partial-onset seizures. Results of presented research demonstrate sustained efficacy in adult patients taking Vimpat® for up to three years, and a consistent long-term tolerability profile.

7 Dec 2009

FDA approves two New Drug Applications

Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced that the US Food and Drug Administration (FDA) has approved its first two New Drug Applications (NDAs) based on its proprietary OralXR+(TM) platform technology including the first-ever 24 hour liquid sustained release product.

7 Dec 2009

ATS Medical's ATS 3f Enable Aortic Bioprosthesis receives European CE Mark approval

ATS Medical, Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced it has received CE Mark approval to distribute the ATS 3f Enable® Aortic Bioprosthesis in the European Union, indicating it is compliant with relevant European health, safety, and environmental protection legislation.

7 Dec 2009

New study reveals RNA may play a critical role in cancer treatment

Researchers from Yale University and Mirna Therapeutics, Inc., reversed the growth of lung tumors in mice using a naturally occurring tumor suppressor microRNA. The study reveals that a tiny bit of RNA may one day play a big role in cancer treatment, and provides hope for future patients battling one of the most prevalent and difficult to treat cancers.

7 Dec 2009

Biolife Solutions, Centocor Research & Development sign license and cGMP manufacturing agreement

BioLife Solutions, Inc., a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, today announced that it has executed a license and custom cGMP manufacturing agreement with Centocor Research & Development, Inc.

7 Dec 2009

Multibillion dollar market opportunity for onsite treatment of regulated medical waste

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors, has issued a special interview with the management team from MedClean Technologies.

7 Dec 2009

New smoke free, electronic cigarettes from Smart Fixx

If you or someone you know wants an alternative to smoking this year, Smart Fixx smokeless electronic cigarettes may be the perfect solution. Also known as electric cigarettes and vapor cigarettes, these smoke free cigs give smokers three big incentives for making this New Year’s resolution stick!

7 Dec 2009

Synexus to complete acquisition of ClinPharm by January 2010

Synexus has agreed to acquire Leipzig based ClinPharm and will complete the acquisition in January 2010. This deal will increase the number of Synexus’ Dedicated Research Centres to 26 in nine countries, thus significantly strengthening its European reach and further reinforcing its position as the global leader.

From AES - Accelerated Enrollment Solutions 7 Dec 2009

Sustainable development: A critical factor against rising global population and climate change

Sustainability is the only way forward for industry that does not lead to an environmental dead-end. Waste recycling has its place, but researchers in France suggest that from the outset the design of a product should consider the whole life cycle to offer any chance of sustainability.

7 Dec 2009

Cubicle Curtain Factory to increase awareness of its innovative hospital privacy curtains

The Cubicle Curtain Factory has retained TransMedia Group to publicize the first major innovation in hospital privacy curtains in decades, the Simply 66 Snap System, which is already saving hospitals millions in maintenance costs.

7 Dec 2009

NEEBC names Amica Mutual Insurance as recipient of 2009 'Best Benefits Practice' award

The New England Employee Benefits Council (NEEBC) named Amica Mutual Insurance as a recipient of the 2009 "Best Benefits Practice" award, presented annually to the companies best exhibiting innovation and creativity in the planning and delivery of their employee benefit programs.

7 Dec 2009

Bristol-Myers Squibb divests its majority stake in Mead Johnson Nutritional

Bristol-Myers Squibb (New York, New York) is divesting its 83% majority stake in its last non-biopharmaceutical holding, Mead Johnson Nutritional (Evansville, Indiana).

7 Dec 2009

Zogenix closes its $35M second tranche of Series B preferred stock financing

Zogenix, Inc., a privately held pharmaceutical company, announced today that it has closed a $35 million second tranche of a Series B preferred stock financing. The Series B round was increased from $51 million, previously announced in September, to $71 million. The additional $20 million investment was made by Chicago Growth Partners, which will now be represented on the Zogenix Board of Directors by Dr. Arda Minocherhomjee.

7 Dec 2009

Discovery presents a vital step towards efficient treatment of vascular injuries

Hyperglycemia starts a complex chain of events that damages blood vessels and cause cardiovascular disease. Scientists at Lund University Diabetes Centre (LUDC) have now been able to demonstrate why this happens, as well as how the destructive chain can be broken.

7 Dec 2009

Medical News

Micromet to present new data from its blinatumomab Phase 1 trial at the ASH meeting

Atrium Medical commences enrollment in its INFUSE AMI trial

New PenLink connectivity package installed at Zwanger-Pesiri Radiology

First Edition: December 7, 2009

Native Remedies selects TransMedia Group as its PR firm

New report shows U.S. citizens are ready to make hard choices on fiscal and economic priorities

UCB presents data on Vimpat AED at AES meeting

FDA approves two New Drug Applications

ATS Medical's ATS 3f Enable Aortic Bioprosthesis receives European CE Mark approval

New study reveals RNA may play a critical role in cancer treatment

Biolife Solutions, Centocor Research & Development sign license and cGMP manufacturing agreement

Multibillion dollar market opportunity for onsite treatment of regulated medical waste

New smoke free, electronic cigarettes from Smart Fixx

Synexus to complete acquisition of ClinPharm by January 2010

Sustainable development: A critical factor against rising global population and climate change

Cubicle Curtain Factory to increase awareness of its innovative hospital privacy curtains

NEEBC names Amica Mutual Insurance as recipient of 2009 'Best Benefits Practice' award

Bristol-Myers Squibb divests its majority stake in Mead Johnson Nutritional

Zogenix closes its $35M second tranche of Series B preferred stock financing

Discovery presents a vital step towards efficient treatment of vascular injuries

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Latest News